Exam Details

Subject elective – i — immunoinformatics
Paper
Exam / Course p.g. diploma in structural pharmacogenomics bioinformatics
Department
Organization alagappa university
Position
Exam Date December, 2017
City, State tamil nadu, karaikudi


Question Paper

P.G. DIPLOMA IN STRUCTURAL
PHARMACOGENOMICS EXAMINATION,
DECEMBER 2017
First Semester
Bioinformatics
Elective I — IMMUNOINFORMATICS
(CBCS 2013 onwards)
Time 3 Hours Maximum 75 Marks
Part A (10 x 2 20)
Answer all questions.
All questions carry equal marks.
1. Fc receptor
2. Opsonin
3. IgE
4. Anti idiotype Antibodies
5. Immunogenomics
6. HLA-B
7. Autoimmunity
8. MHC class III
9. MHC ligands
10. Alignments.
Sub. Code
510501
RW-1396
2
Wk 3
Part B x 5 25)
Answer all questions.
All questions carry equal marks.
11. Explain the concepts of antigen processing and
presentation with a suitable example.
Or
Enumerate the advantages and disadvantages of
monoclonal antibodies.
12. Describe the various factors responsible for
autoimmunity.
Or
Give an account on B cell surface receptor for
antigen.
13. Explain toxoids and how are they used in
vaccination.
Or
Comment on IMGT/HLA sequence database.
14. Explain the mathematical models of HIV.
Or
Write a short note on MHC polymorphism.
15. Give an account on Epitopes databases.
Or
Explain the uses of predicting 3D structure in
antibody homology modeling.
RW-1396
3
Wk 3
Part C x 10 30)
Answer any three questions.
All questions carry equal marks.
16. Write an essay on humoral and cellular immunity.
17. Discuss the functions of class I and II MHC Molecules.
18. Give a brief account on Vaccine design and application of
therapeutic vaccines.
19. Give a detail note on viral informatics with suitable
example.
20. Explain the various methods applied in immunological
bioinformatics tools.
————————


Other Question Papers

Subjects

  • elective – i — immunoinformatics
  • lab i : computer aided drug designing (theory)
  • lab ii : structural biology (theory)
  • molecular cell biology and genetic engineering
  • molecular modeling and drug designing
  • pharmacogenomics
  • small and macromolecular x-ray crystallography